Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department
Patients diagnosed with cannabinoid hyperemesis syndrome that are safe for discharge from the emergency department will be sent an outpatient prescription for …
Cannabinoid Hyperemesis Syndrome
Estimated
~$10 – $6,250
University of Illinois at ChicagoNCT07726069
Phase 3
Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
The aim of the study is to identify which medication (haloperidol or olanzapine) is most effective in treating nausea and abdominal pain associated with cannab…
Cannabinoid Hyperemesis Syndrome
Estimated
~$10 – $6,250
Mercy Bon Secours Saint Vincent Medical CenterNCT07246187